Plain-English translation of NCT07088874 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Doctors know that about 4 in 10 patients develop acute kidney injury (sudden loss of kidney function) after having one kidney removed surgically. Currently, doctors diagnose this injury using standard blood and urine tests, but these tests often detect problems too late. This study is looking for new biological markers—early warning signs in your blood—that could predict kidney injury sooner and help doctors protect your remaining kidney.
Standard kidney tests are slow to show problems and can miss early damage. By finding better, faster markers, doctors hope to catch kidney injury earlier and prevent it from becoming a long-term problem after surgery.
You likely qualify if…
You likely don't qualify if…
You would have blood samples collected before your kidney removal surgery and at several time points afterward to monitor for kidney injury markers. The study will follow you for about one year after surgery to see if any new markers can predict acute kidney injury or long-term kidney problems. Beyond the blood draws (which are routine during surgery and follow-up visits), there are no special medications or lifestyle changes required.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
China
Enrollment target
~60 participants
Started
August 2025
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Qiongfang Wu, MD
Peking University First Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.